AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36410210 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorlatinib
Number of subjects: 288
Study 36410210 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 288
Study 35273175 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung recruitment maneuver (LRM) in the semi-lateral position
Number of subjects: 79
Study 35273175 — intervention group
Group type: COMPARATOR
Intervention: Lung recruitment maneuver (LRM) in the supine position
Number of subjects: 79
Study 33939335 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 165
Study 33939335 — intervention group
Group type: COMPARATOR
Intervention: Curative resection
Number of subjects: 165
Study 32513495 — intervention group
Group type: EXPERIMENTAL
Intervention: Abaloparatide
Number of subjects: 296
Study 32513495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study 32513495 — intervention group
Group type: COMPARATOR
Intervention: Teriparatide
Number of subjects: 296
Study 35794067 — intervention group
Group type: EXPERIMENTAL
Intervention: OPC-61815 (16-mg injection)
Number of subjects: 294
Study 35794067 — intervention group
Group type: COMPARATOR
Intervention: Oral tolvaptan (15-mg tablet)
Number of subjects: 294
Study 33548206 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) injection (3.5mL)
Number of subjects: 26
Study 33548206 — intervention group
Group type: COMPARATOR
Intervention: Normal saline injection (3.5mL)
Number of subjects: 26
Study 32495521 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiment group (n = 62) received 600 mg/d of calcium carbonate, 0.5 μg/d of alfacalcidol, and 70 mg/week of alendronate for 18 months
Number of subjects: 123
Study 32495521 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 61) received 600 mg/d of calcium carbonate and 0.5 μg/d of alfacalcidol for 18 months
Number of subjects: 123
Study 34592854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting survival rates
Number of subjects: 9739
Study 34592854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting 3-year survival rate
Number of subjects: 9739
Study 34592854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting 5-year survival rate
Number of subjects: 9739
Study 35360212 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic dance group (3 times per week for 3 months)
Number of subjects: 68
Study 35360212 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study 32030555 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser (0.58 W) + TiF4
Number of subjects: 90
Study 32030555 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser (0.58 W) + AmF/NaF/SnCl2
Number of subjects: 90
Study 32030555 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser (0.69 W) + TiF4
Number of subjects: 90
Study 32030555 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser (0.69 W) + AmF/NaF/SnCl2
Number of subjects: 90
Study 32030555 — intervention group
Group type: EXPERIMENTAL
Intervention: AmF/NaF/SnCl2
Number of subjects: 90
Study 32030555 — intervention group
Group type: EXPERIMENTAL
Intervention: TiF4
Number of subjects: 90
Study 32030555 — intervention group
Group type: COMPARATOR
Intervention: Negative control (deionized water)
Number of subjects: 90
Study 33715258 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2% simvastatin (SIM) gel covered with polypropylene membranes (PPPM)
Number of subjects: 26
Study 33715258 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel covered with polypropylene membranes (PPPM)
Number of subjects: 26
Study 32565464 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised patient actor (SP) training intervention consisting of lectures, role-playing with SPs and group debriefing.
Number of subjects: 24
Study 32565464 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group).
Number of subjects: 24
Study 32571889 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual thromboprophylaxis (mechanical thromboprophylaxis with sequential compression devices and 28-day prophylaxis with low molecular weight heparin)
Number of subjects: 534
Study 32571889 — intervention group
Group type: COMPARATOR
Intervention: Pre-intervention (low molecular weight heparin during admission and extended 28-day prophylaxis at surgeon's discretion)
Number of subjects: 534
Study 33407547 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Tuina plus usual care
Number of subjects: 86
Study 33407547 — intervention group
Group type: COMPARATOR
Intervention: Sham Tuina plus usual care
Number of subjects: 86
Study 32723696 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized embryo transfer (PET) guided by endometrial receptivity analysis (ERA)
Number of subjects: 458
Study 32723696 — intervention group
Group type: COMPARATOR
Intervention: Frozen embryo transfer (FET)
Number of subjects: 458
Study 32723696 — intervention group
Group type: COMPARATOR
Intervention: Fresh embryo transfer
Number of subjects: 458
Study 32723696 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized embryo transfer (PET)
Number of subjects: 458
Study 36225172 — intervention group
Group type: COMPARATOR
Intervention: EBV‐miR‐BART5‐3p inhibitor
Number of subjects: 0
Study 36225172 — intervention group
Group type: COMPARATOR
Intervention: EBV‐miR‐BART5‐3p inhibitors
Number of subjects: 0
Study 36225172 — intervention group
Group type: COMPARATOR
Intervention: EBV‐miR‐BART5‐3p mimics
Number of subjects: 0
Study 36225172 — intervention group
Group type: COMPARATOR
Intervention: EBV‐miR‐BART5‐3p
Number of subjects: 0
Study 34213471 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate nostril breathing (ANB) exercise for 4 weeks
Number of subjects: 100
Study 34213471 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 33801691 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT10 (48 × 10 s bouts at 100% of peak power with 15 s of recovery)
Number of subjects: 16
Study 33801691 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT60 (8 × 60 s bouts at 100% of peak power with 90 s of recovery)
Number of subjects: 16
Study 36454387 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Postural Control Exercise (PPCE)
Number of subjects: 34
Study 36454387 — intervention group
Group type: COMPARATOR
Intervention: Core Stability Exercise (CSE)
Number of subjects: 34
Study 36454387 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PPCE and CSE
Number of subjects: 34
Study 33407488 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracheck Pf® Test
Number of subjects: 702
Study 33407488 — intervention group
Group type: EXPERIMENTAL
Intervention: ICT Malaria Pf™ Cassette Test
Number of subjects: 702
Study 33407488 — intervention group
Group type: COMPARATOR
Intervention: Microscopy
Number of subjects: 702
Study 33407488 — intervention group
Group type: COMPARATOR
Intervention: Polymerase Chain Reaction (PCR)
Number of subjects: 702
Study 32878708 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-214 (15 μg GI.1 and 50 μg GII.4c VLPs, 0.5 mg Al(OH)3)
Number of subjects: 4712
Study 32878708 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 4712
Study 32878708 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-214
Number of subjects: 4712
Study 616670476 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiation therapy (IMRT)
Number of subjects: 60
Study 616670476 — intervention group
Group type: COMPARATOR
Intervention: Volumetric-modulated arc therapy (VMAT)
Number of subjects: 60
Study 33775198 — intervention group
Group type: EXPERIMENTAL
Intervention: treadmill training with bilateral anodal tDCS
Number of subjects: 80
Study 33775198 — intervention group
Group type: EXPERIMENTAL
Intervention: treadmill training with unilateral anodal tDCS
Number of subjects: 80
Study 33775198 — intervention group
Group type: COMPARATOR
Intervention: treadmill training with sham tDCS
Number of subjects: 80
Study 33775198 — intervention group
Group type: COMPARATOR
Intervention: treadmill training (no tDCS)
Number of subjects: 80
Study 35073324 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperonyl butoxide (PBO) pre-exposure followed by permethrin exposure in CDC bottle bioassays
Number of subjects: 0
Study 35073324 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic dose bioassays using permethrin
Number of subjects: 0
Study 35073324 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcriptomic analysis
Number of subjects: 0
Study 32755086 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambu Aura-i
Number of subjects: 57
Study 32755086 — intervention group
Group type: COMPARATOR
Intervention: Ambu Aura Gain
Number of subjects: 57
Study 35551341 — intervention group
Group type: EXPERIMENTAL
Intervention: RD43 rice (Glycemic Index [GI] = 78) containing 14.1 g of undigestible starch daily as a substitute for two meals per day
Number of subjects: 34
Study 35551341 — intervention group
Group type: EXPERIMENTAL
Intervention: RD43 rice
Number of subjects: 34
Study 35551341 — intervention group
Group type: COMPARATOR
Intervention: Taiken9 rice (GI = 98)
Number of subjects: 34
Study 33127241 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay counselor–delivered school intervention
Number of subjects: 5539
Study 33127241 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurturing school environment (mediated by school climate)
Number of subjects: 5539
Study 36451178 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional Cash Transfers (CCT)
Number of subjects: 39
Study 36451178 — intervention group
Group type: COMPARATOR
Intervention: Non-recipients (Control)
Number of subjects: 39
Study 34115148 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (17 mmol/l) with 5 mU [m2 BSA]−1 min−1 insulin
Number of subjects: 0
Study 33745739 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged postoperative mechanical ventilation (PPMV) defined as cumulative postoperative mechanical ventilation exceeding 72 h
Number of subjects: 108392
Study 33745739 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal age
Number of subjects: 108392
Study 33745739 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative inotropic support
Number of subjects: 108392
Study 33745739 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative time longer than 150 min
Number of subjects: 108392
Study 33745739 — intervention group
Group type: EXPERIMENTAL
Intervention: American Society of Anesthesiologists classification >3
Number of subjects: 108392
Study 34609548 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized oral care bundle
Number of subjects: 3260
Study 34609548 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine
Number of subjects: 3260
Study 32492354 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 0
Study 32492354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34673744 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gelTM
Number of subjects: 90
Study 34673744 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA SupremeTM
Number of subjects: 90
Study 34673744 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambu AuraGainTM
Number of subjects: 90
Study 34673744 — intervention group
Group type: EXPERIMENTAL
Intervention: All devices
Number of subjects: 90
Study 34823545 — intervention group
Group type: EXPERIMENTAL
Intervention: EDNA training group
Number of subjects: 17
Study 34823545 — intervention group
Group type: COMPARATOR
Intervention: Control group (GRASP training)
Number of subjects: 17
Study 32534578 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg ipragliflozin daily
Number of subjects: 110
Study 32534578 — intervention group
Group type: COMPARATOR
Intervention: Continuation of background treatment (non-SGLT2i)
Number of subjects: 110
Study 35988175 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium nanoparticles topically
Number of subjects: 80
Study 35988175 — intervention group
Group type: COMPARATOR
Intervention: Control (conventional placebo)
Number of subjects: 80
Study 33710588 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex weight-reducing interventions (structured weight reduction programme and sleeve gastrectomy when indicated)
Number of subjects: 160
Study 33710588 — intervention group
Group type: COMPARATOR
Intervention: Standard post-ablation medical care
Number of subjects: 160
Study 32191193 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-Guided Arterial Cannulation (USGAC)
Number of subjects: 60
Study 32191193 — intervention group
Group type: COMPARATOR
Intervention: Traditional Arterial Cannulation (AC)
Number of subjects: 60
Study 35406038 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol supplementation
Number of subjects: 7
Study 35406038 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 7
Study 34856777 — intervention group
Group type: EXPERIMENTAL
Intervention: BATHE consultation model
Number of subjects: 104
Study 34856777 — intervention group
Group type: COMPARATOR
Intervention: Usual care model (SOAP)
Number of subjects: 104
Study 35883392 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of microfragmented adipose tissue
Number of subjects: 40
Study 35883392 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 40
Study 35746825 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 300
Study 35746825 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined educational and technological intervention
Number of subjects: 300
Study 35746825 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 300
Study 33181788 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant nevirapine
Number of subjects: 2025
Study 33181788 — intervention group
Group type: EXPERIMENTAL
Intervention: High HBV VL
Number of subjects: 2025
Study 33181788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2025
Study 36378149 — intervention group
Group type: EXPERIMENTAL
Intervention: iRoot SP (bioceramic sealer)
Number of subjects: 76
Study 36378149 — intervention group
Group type: COMPARATOR
Intervention: AH Plus (resin-based sealer)
Number of subjects: 76
Study 33933894 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg buprenorphine
Number of subjects: 42
Study 33933894 — intervention group
Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 42
Study 32800303 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavior treatment (CBT)
Number of subjects: 47
Study 35190442 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal tolerated ACE-I/ARB and spironolactone with patiromer
Number of subjects: 140
Study 35190442 — intervention group
Group type: COMPARATOR
Intervention: Maximal tolerated ACE-I/ARB and spironolactone without patiromer
Number of subjects: 140
Study 34139356 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohort multiple randomised controlled trial (cmRCT) design
Number of subjects: 0
Study 32147072 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.25 g ginsenoside Rg3-enriched KRG & AG co-administration
Number of subjects: 80
Study 32147072 — intervention group
Group type: COMPARATOR
Intervention: Control (standard of care)
Number of subjects: 80
Study 33973154 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patches
Number of subjects: 22
Study 33973154 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 34645102 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency stimulation of the suprascapular nerve
Number of subjects: 20
Study 34645102 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular corticosteroid injection
Number of subjects: 20
Study 35593540 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-hour group disclosure intervention
Number of subjects: 38
Study 35593540 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 38
Study 33411130 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional microneedle radiofrequency (MRF)
Number of subjects: 14
Study 33411130 — intervention group
Group type: COMPARATOR
Intervention: 1565-nm non-ablative fractional laser (NAFL)
Number of subjects: 14
Study 33411130 — intervention group
Group type: EXPERIMENTAL
Intervention: Both NAFL and MRF
Number of subjects: 14
Study 32646502 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard outpatient treatment plus prednisone (60 mg/24 h for 3 days, 30 mg/24 h for 3 days, and 15 mg/24 h for 3 days)
Number of subjects: 200
Study 32646502 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient treatment only (paracetamol 1 g/8 h on demand + hydroxychloroquine 400 mg/12h first day, 200 mg/12 h for 4 days + azithromycin 500 mg/24h for 5 days)
Number of subjects: 200
Study 32646502 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard outpatient treatment plus prednisone
Number of subjects: 200
Study 35927929 — intervention group
Group type: EXPERIMENTAL
Intervention: Baska mask
Number of subjects: 64
Study 35927929 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal intubation (ET)
Number of subjects: 64
Study 34174104 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (PE teachers received training to support psychological needs)
Number of subjects: 1168
Study 34174104 — intervention group
Group type: COMPARATOR
Intervention: Control group (PE teachers received no training)
Number of subjects: 1168
Study 32651046 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35166922 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous rHuEPO 50 U/kg three times weekly until discharge
Number of subjects: 24
Study 35166922 — intervention group
Group type: COMPARATOR
Intervention: RBC transfusion if hemoglobin ≤ 7 g/dL and/or hemodynamic instability
Number of subjects: 24
Study 35166922 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline EPO levels
Number of subjects: 24
Study 35166922 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline lactic dehydrogenase levels
Number of subjects: 24
Study 35166922 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum lactic dehydrogenase levels
Number of subjects: 24
Study 35166922 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatinine peak
Number of subjects: 24
Study 35166922 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis duration
Number of subjects: 24
Study 35166922 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 24
Study 32673006 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy (COPE)
Number of subjects: 81
Study 32673006 — intervention group
Group type: COMPARATOR
Intervention: Seeking Safety (non-exposure intervention)
Number of subjects: 81
Study 32673006 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 81
Study 34052365 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg ibuprofen
Number of subjects: 20
Study 34052365 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg ibuprofen
Number of subjects: 20
Study 34052365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34052365 — intervention group
Group type: EXPERIMENTAL
Intervention: PPARγ gene expression
Number of subjects: 20
Study 36086543 — intervention group
Group type: EXPERIMENTAL
Intervention: PsmPy package for propensity score matching
Number of subjects: 0
Study 36086543 — intervention group
Group type: COMPARATOR
Intervention: MatchIt package for propensity score matching
Number of subjects: 0
Study 33879566 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching intervention including mental practice exercises
Number of subjects: 24
Study 33879566 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mental practice exercises)
Number of subjects: 24
Study 35697601 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined sport-specific cognitive tests and 35-minute cycling time trial
Number of subjects: 25
Study 35697601 — intervention group
Group type: COMPARATOR
Intervention: 35-minute cycling time trial
Number of subjects: 25
Study 35697601 — intervention group
Group type: COMPARATOR
Intervention: Sport-specific cognitive tests
Number of subjects: 25
Study 33337729 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaco-invasive approach using streptokinase
Number of subjects: 266
Study 33337729 — intervention group
Group type: COMPARATOR
Intervention: Early PPCI (?3 hrs)
Number of subjects: 266
Study 34866234 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous vitamin C (2.5 g/6 h for 96 hours)
Number of subjects: 80
Study 32971388 — intervention group
Group type: EXPERIMENTAL
Intervention: Addiction warning
Number of subjects: 1000
Study 32971388 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosis warning
Number of subjects: 1000
Study 32971388 — intervention group
Group type: EXPERIMENTAL
Intervention: Any warning
Number of subjects: 1000
Study 32971388 — intervention group
Group type: EXPERIMENTAL
Intervention: Driving warning
Number of subjects: 1000
Study 32971388 — intervention group
Group type: COMPARATOR
Intervention: No warning
Number of subjects: 1000
Study 33323233 — intervention group
Group type: EXPERIMENTAL
Intervention: RELF method (three-lead detection system with an automatic algorithm)
Number of subjects: 64
Study 33323233 — intervention group
Group type: EXPERIMENTAL
Intervention: RELF method
Number of subjects: 64
Study 36409356 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided dual technique
Number of subjects: 24
Study 36409356 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 24
Study 36409356 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 24
Study 36451142 — intervention group
Group type: EXPERIMENTAL
Intervention: ClearlyMe® (self-directed use)
Number of subjects: 489
Study 36451142 — intervention group
Group type: EXPERIMENTAL
Intervention: ClearlyMe® with guided SMS support (guided use)
Number of subjects: 489
Study 36451142 — intervention group
Group type: COMPARATOR
Intervention: Digital psychoeducation (attention-matched control)
Number of subjects: 489
Study 36451142 — intervention group
Group type: EXPERIMENTAL
Intervention: ClearlyMe® (self-directed use) and ClearlyMe® with guided SMS support
Number of subjects: 489
Study 32369661 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Plasma Exchanges (TPE)
Number of subjects: 38
Study 32369661 — intervention group
Group type: COMPARATOR
Intervention: Sham-TPE
Number of subjects: 38
Study 36894736 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress condition (n = 24)
Number of subjects: 48